XFRA NEW INSTRUMENTS AVAILABLE ON XETRA

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 17.07.2024

The following instruments on XETRA do have their first trading 17.07.2024
Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 17.07.2024

Aktien

1 SE0022062055 Prisma Properties AB
2 US79588J1025 Sampo OYJ ADR
3 AU0000079212 AML3D Ltd.

4 AU000000RAC3 Race Oncology Ltd.
5 IT0005595423 Sys Dat S.p.A.
6 AU000000TLX2 Telix Pharmaceuticals Ltd.
7 NZNEUE0001S8 Neuren Pharmaceuticals Ltd.
8 CA75604K1075 Realbotix Corp.

Anleihen/ETF

1 US879273AU43 Telecom Argentina S.A.
2 CA135087S216 Canada, Government of...
3 DE000DW6AEH2 DZ BANK AG
4 DE000DW6AEJ8 DZ BANK AG
5 DE000DW6AEG4 DZ BANK AG
6 AT0000A3DNW5 Erste Group Bank AG
7 US04686E4E96 Athene Global Funding
8 USP9028NBT74 Telecom Argentina S.A.
9 DE000HLB44C9 Landesbank Hessen-Thüringen Girozentrale
10 DE000HLB4397 Landesbank Hessen-Thüringen Girozentrale
11 IE000GLIXPP3 AXA IM MSCI Emerging Markets Equity PAB UCITS ETF

Zeit	Aktuelle Nachrichten
So	AML3D LIMITED: Investor Presentation - New US defence markets open to AML3D
24.02.	AML3D LIMITED: Half Yearly Report and Accounts
23.02.	AML3D LIMITED: 2025 Interim Results Presentation
28.01.	AML3D LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report
22.01.	AML3D LIMITED: Unquoted Option terms and conditions

Zeit

Aktuelle Nachrichten

AML3D LIMITED: Investor Presentation - New US defence markets open to AML3D

24.02.

AML3D LIMITED: Half Yearly Report and Accounts

23.02.

AML3D LIMITED: 2025 Interim Results Presentation

28.01.

AML3D LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report

22.01.

AML3D LIMITED: Unquoted Option terms and conditions

Zeit	Aktuelle Nachrichten
Fr	NEUREN PHARMACEUTICALS LIMITED: Update - Notification of buy-back - NEU
Di	NEUREN PHARMACEUTICALS LIMITED: Notification of cessation of securities - NEU
Di	NEUREN PHARMACEUTICALS LIMITED: Update - Notification of buy-back - NEU
Di	NEUREN PHARMACEUTICALS LIMITED: Appendix 4G
Di	NEUREN PHARMACEUTICALS LIMITED: 2024 Annual Report to shareholders

Zeit

Aktuelle Nachrichten

NEUREN PHARMACEUTICALS LIMITED: Update - Notification of buy-back - NEU

NEUREN PHARMACEUTICALS LIMITED: Notification of cessation of securities - NEU

NEUREN PHARMACEUTICALS LIMITED: Update - Notification of buy-back - NEU

NEUREN PHARMACEUTICALS LIMITED: Appendix 4G

NEUREN PHARMACEUTICALS LIMITED: 2024 Annual Report to shareholders

Zeit	Aktuelle Nachrichten
21.02.	Prisma Properties zeigt beeindruckende Umsatzsteigerung
19.02.	Prisma Properties AB: Prisma Properties Year-End Report Q4 2024	Q4, October - December 2024 Rental income: SEK 102 (100) million Net operating income: SEK 90 (93) million Net financial items: SEK -29 (-59) million Profit from property management: SEK 47 (15) million... ► Artikel lesen
13.01.	Prisma Properties AB: Prisma strengthens its presence along Sweden's highways - acquires five properties for SEK 88 million	Prisma Properties (publ) has entered into an agreement to acquire five strategically located properties along highways E4, E18, and E20 in Sweden. The underlying property value amounts to SEK 88 million... ► Artikel lesen
16.12.24	Prisma Properties AB: Prisma continues to grow with Food Folk Sverige and McDonald's - signs long lease agreement in Eksjö	Prisma Properties (publ) has signed a 20-year lease agreement with Food Folk Sverige AB, development licensee of McDonald's in Sweden, for the development of a new McDonald's restaurant in Prisma's... ► Artikel lesen
06.11.24	Prisma Properties AB: Prisma Properties Interim Report Q3 2024	Q3, July - September 2024Rental income: SEK 98 (85) millionNet operating income: SEK 88 (75) millionNet financial items: SEK -28 (-51) millionProfit from property management: SEK 46 (12) millionAdjusted... ► Artikel lesen

Zeit

Aktuelle Nachrichten

21.02.

Prisma Properties zeigt beeindruckende Umsatzsteigerung

19.02.

Prisma Properties AB: Prisma Properties Year-End Report Q4 2024

Q4, October - December 2024 Rental income: SEK 102 (100) million Net operating income: SEK 90 (93) million Net financial items: SEK -29 (-59) million Profit from property management: SEK 47 (15) million...
► Artikel lesen

13.01.

Prisma Properties AB: Prisma strengthens its presence along Sweden's highways - acquires five properties for SEK 88 million

Prisma Properties (publ) has entered into an agreement to acquire five strategically located properties along highways E4, E18, and E20 in Sweden. The underlying property value amounts to SEK 88 million...
► Artikel lesen

16.12.24

Prisma Properties AB: Prisma continues to grow with Food Folk Sverige and McDonald's - signs long lease agreement in Eksjö

Prisma Properties (publ) has signed a 20-year lease agreement with Food Folk Sverige AB, development licensee of McDonald's in Sweden, for the development of a new McDonald's restaurant in Prisma's...
► Artikel lesen

06.11.24

Prisma Properties AB: Prisma Properties Interim Report Q3 2024

Q3, July - September 2024Rental income: SEK 98 (85) millionNet operating income: SEK 88 (75) millionNet financial items: SEK -28 (-51) millionProfit from property management: SEK 46 (12) millionAdjusted...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Mi	RACE ONCOLOGY LTD: RC220 Phase 1 Trial Opens for Patient Enrolment
Mo	RACE ONCOLOGY LTD: Ethics approval for RC220 Trial at Gosford Wyong Hospitals
27.03.	RACE ONCOLOGY LTD: Race Initiates First AU Site for Phase 1 Solid Tumour Trial
17.03.	RACE ONCOLOGY LTD: Race Investor Presentation
14.03.	Race Oncology approved for Phase I trial for chemotherapeutic treatments

Zeit

Aktuelle Nachrichten

RACE ONCOLOGY LTD: RC220 Phase 1 Trial Opens for Patient Enrolment

RACE ONCOLOGY LTD: Ethics approval for RC220 Trial at Gosford Wyong Hospitals

27.03.

RACE ONCOLOGY LTD: Race Initiates First AU Site for Phase 1 Solid Tumour Trial

17.03.

RACE ONCOLOGY LTD: Race Investor Presentation

14.03.

Race Oncology approved for Phase I trial for chemotherapeutic treatments

Zeit	Aktuelle Nachrichten
21.02.	Bewertungsdifferenz als Chance: Während Figure AI von Milliarden spricht, verdient dieses €60M -Unternehmen tatsächlich Geld!
19.02.	Realbotix targets expansion with 250+ robot assembly by 2026
18.02.	Realbotix verbessert humanoide Roboter mit KI-Vision-System
18.02.	Realbotix: KI-Vision-System macht humanoide Roboter realistischer
18.02.	Breaking News: KI + Robotik = 39,5 Mrd. $! Figure AI hat das Spiel gerade verändert!!

Zeit

Aktuelle Nachrichten

21.02.

Bewertungsdifferenz als Chance: Während Figure AI von Milliarden spricht, verdient dieses €60M -Unternehmen tatsächlich Geld!

19.02.

Realbotix targets expansion with 250+ robot assembly by 2026

18.02.

Realbotix verbessert humanoide Roboter mit KI-Vision-System

18.02.

Realbotix: KI-Vision-System macht humanoide Roboter realistischer

18.02.

Breaking News: KI + Robotik = 39,5 Mrd. $! Figure AI hat das Spiel gerade verändert!!

Zeit	Aktuelle Nachrichten
17.07.24	XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 17.07.2024		The following instruments on XETRA do have their first trading 17.07.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 17.07.2024 Aktien 1 SE0022062055 Prisma Properties AB 2... ► Artikel lesen

Zeit

Aktuelle Nachrichten

17.07.24

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 17.07.2024

The following instruments on XETRA do have their first trading 17.07.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 17.07.2024 Aktien 1 SE0022062055 Prisma Properties AB 2...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Do	TELIX PHARMACEUTICALS LIMITED: Notification of cessation of securities - TLX
Do	TELIX PHARMACEUTICALS LIMITED: Application for quotation of securities - TLX
Do	TELIX PHARMACEUTICALS LIMITED: Pending Release of Shares from Voluntary Escrow
Mi	TELIX PHARMACEUTICALS LIMITED: App 3X Initial Director Interests - A Whitaker
Mi	TELIX PHARMACEUTICALS LIMITED: Anne Whitaker Appointed as Non-Executive Director

Zeit

Aktuelle Nachrichten

TELIX PHARMACEUTICALS LIMITED: Notification of cessation of securities - TLX

TELIX PHARMACEUTICALS LIMITED: Application for quotation of securities - TLX

TELIX PHARMACEUTICALS LIMITED: Pending Release of Shares from Voluntary Escrow

TELIX PHARMACEUTICALS LIMITED: App 3X Initial Director Interests - A Whitaker

TELIX PHARMACEUTICALS LIMITED: Anne Whitaker Appointed as Non-Executive Director

Unternehmen / Aktien	Kurs	%
AML3D LIMITED	0,080	-9,09 %
NEUREN PHARMACEUTICALS LIMITED	5,050	-9,01 %
PRISMA PROPERTIES AB	2,175	-0,91 %
RACE ONCOLOGY LTD	0,605	-4,72 %
REALBOTIX CORP	0,150	-7,41 %
SYS-DAT SPA	6,560	+4,13 %
TELIX PHARMACEUTICALS LIMITED	12,400	+1,64 %

Unternehmen / Aktien

Kurs

AML3D LIMITED

0,080

-9,09 %

NEUREN PHARMACEUTICALS LIMITED

5,050

-9,01 %

PRISMA PROPERTIES AB

2,175

-0,91 %

RACE ONCOLOGY LTD